Ruti Aga's Six Years: A Forged Prescription Cancelled the Defence That May Have Been Genuine

The clinic that issued the prescription does not exist. The person who signed it is a family member with no medical registration. And the pad it came off, by his own account, was an "old one lifted from a former workplace" — a workplace that now flatly denies such a pad was ever its own. One sheet of paper, three verification failures. When I talked my way into Bhubaneswar's Kalinga Stadium in 2026 without a camera crew, counting Neeraj Chopra's six attempts frame by frame through a borrowed 70-200mm lens, the lesson settled in early: athletics never tells its real story on the scoreboard. It tells it in the paperwork nobody wants to read.

What the Athletics Integrity Unit (AIU) released on Thursday is not a performance report. It is a ledger entry. Ethiopian marathoner Ruti Aga, 32, has been handed a six-year ban. The clock runs from 10 September — and she had already been provisionally suspended from 10 September, so that date is no discount, merely the same clock recorded on paper. A sample taken after she won a half marathon in China in March returned methylprednisolone. The sanction splits into two tranches: two years for the presence of a substance, four years for tampering.

One correction needs to be made here, because a large slice of the coverage is printing it wrong. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid — WADA Prohibited List class S9 — and the defining condition of S9 is that it is prohibited in-competition only, by injection, oral or rectal route. An out-of-competition knee injection is entirely legal. The question in this case was never whether an anabolic steroid was taken. It was which route, and exactly how many hours before the gun. A road race's testing window opens at 23:59 the night before, so an injection given days earlier still lands inside it. That technical hinge is the entire legal fulcrum of this case.

This is where Aga destroyed her own strongest defence. Suppose she had held a real record: a documented knee injury, the injection date, the hours counted back to the start, and a TUE filed where needed. The case then settles well under two years, or possibly at no sanction at all. The athlete chose a fabricated document over a real one, and that single choice burned the defence that may have been true. When an athlete forges paperwork, he kills the most credible witness to his own innocence.

The two-plus-four arithmetic is the most revealing thing here. Two years for presence is the standard range for a Specified Substance, meaning the panel did not find proven intent to cheat. Four years for tampering is the Code's default. The maths says the panel treated the substance as minor and the document as fully culpable. The paradox is sharp: forged documentation is itself circumstantial evidence of concealment intent, yet it did not escalate the presence sanction. The two penalties were booked into separate accounts.

Now the part without which this case cannot be read. There is no illicit substance at the root of a six-year ban — there is a team physician who does not exist. Imagine Aga had a registered team doctor shadowing her, as every serious marathon squad should have. Then there is a real record of the knee injection, a washout calculation and either a TUE on file or no need for one. Nothing has to be fabricated at all. Aga's case is bigger than one cheat's story. It is the story of the gap that has opened between athlete and medical system across several East African road-racing camps — where knee pain is the largest financial risk and the cheapest fix is also the easiest. Every shutdown invents a quota economy, and every quota economy hides a queue; here the queue is injured runners reaching for the most accessible tool, because refusing to race in an appearance-fee market is the most expensive decision available.

That half marathon in China is itself a signal. Aga won it in March, which means a label-tier elite field with in-competition testing. No time, split or field depth is recorded in the source, so any performance judgment would be pure guesswork. But one conclusion holds: China's label-race circuit has become a thick, low-risk income layer for East African marathoners. That same layer is now the AIU's most fertile testing ground. The appearance-fee economy and the testing economy are colliding inside the same races, and each is accelerating the other.

The post-race accounting is this. Aga is 32; a return after six years puts her near 38. Ethiopia's women's marathon depth is such that a 2:18 runner is not automatically selectable. Returning at 38 with a doping record means six years on paper and a career over in practice. The record that survives is the 2026 Tokyo Marathon title and three World Marathon Major second places, including Berlin 2026 and Tokyo 2026. Since the violation is anchored to that March race and no earlier use was found, the old titles are not automatically annulled. But the March win, its prize money and any ranking points accrued thereafter will almost certainly be voided — automatic disqualification of the race where the sample was collected is standard AIU practice.

Here is what stings most, and what I keep seeing dismissed into one of two lazy bins. The substance that drew a six-year ban has no proven endurance benefit. A glucocorticoid reduces pain and swelling — it treats injury, it does not fuel speed. Yet an Ethiopian road runner absorbed a sanction that frequently does not fall even on genuine anabolic-steroid cases. I will not dismiss this by simply calling the AIU harsh. Its harshness sits on the paper, not the substance, and that distinction is the whole point. The six years are not for a drug and not for a performance aid — they are for a prescription.

And here the infrastructure gap shows plainly, the same logic I learned to read from the quota ledgers of Indian athletics. Behind a European athlete stands a team doctor, insurance and a TUE accounting system; an African road runner's entourage often shrinks to a relative. The result is that one identical mistake hands one athlete a defence and the other a career. Equality of sanction exists on paper; equality of protection does not. The four-year tampering charge sharpens the gap further, because it arrived not from a document alone but from an interview — from statements made under questioning. That is the point where language, translation and pressure conditions directly set the length of a ban. These nuances have drawn sustained questions about the AIU's investigative process, and this case will add fuel.

What is the sanction's effect on Ethiopia's national team? Measurably zero. Aga's three Major podiums were commercial-tier results, not championship conversions. Her removal does not dent Ethiopia's medal capacity by an inch. So this is no competition story; it is a governance story. And the governance pattern emerging is that the tampering charge keeps returning in AIU road-racing cases. The meaning is clear: the investigative frontier has shifted from catching substances to checking documents. Aga's case is a complete specimen of that new frontier — where the real offence is proven not in the first violation but in the attempt to explain it away.

The forward accounting runs like this. China's label circuit stays the hottest surveillance zone — big appearance fees, dense African elite fields and heavy AIU presence in one place. The second watch is on which national federations open a TUE account and which do not; where a country has no standing line of team physicians, more Ruti Aga prescriptions will tear. The sanction for forged documentation has sent the message that deceiving on paper is expensive. The question is not how many get caught next. It is how many, before getting caught, are given the room to write a real one.